NZ$45.00
0.22%
New Zealand Exchange, Fri, Sep 25 2026.
ISIN
NZFAPE0001S2
Symbol
FPH
Index

Fisher & Paykel Healthcare Target price 2026 - Analyst rating & recommendation

Fisher & Paykel Healthcare Classifications & Recommendation

Buy
53%
Hold
47%

Fisher & Paykel Healthcare Price Target

Target Price NZ$47.43
Price NZ$45.00
Potential
Number of Estimates 12
12 Analysts have issued a price target Fisher & Paykel Healthcare 2027 . The average Fisher & Paykel Healthcare target price is NZ$47.43. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 15 analysts: 8 Analysts recommend Fisher & Paykel Healthcare to buy, 7 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Fisher & Paykel Healthcare stock has an average upside potential 2027 of . Most analysts recommend the Fisher & Paykel Healthcare stock at Purchase.

Sales and Margin forecast 2027, 2028 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Mar '26 2027
Estimates
Revenue Billion NZ$ 2.31 2.59
14.22% 12.16%
Net Margin 20.30% 21.74%
8.74% 7.12%

15 Analysts have issued a sales forecast Fisher & Paykel Healthcare 2027 . The average Fisher & Paykel Healthcare sales estimate is

NZ$2.6b
unlock
. This is
12.16% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
NZ$2.7b 18.83%
unlock
, the lowest is
NZ$2.5b 7.13%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026 NZ$2.3b 14.22%
2027
NZ$2.6b 12.16%
unlock
2028
NZ$2.9b 11.78%
unlock
2029
NZ$3.2b 11.68%
unlock
2030
NZ$3.7b 12.93%
unlock

15 Fisher & Paykel Healthcare Analysts have issued a net profit forecast 2027. The average Fisher & Paykel Healthcare net profit estimate is

NZ$563m
unlock
. This is
20.12% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
NZ$610m 30.10%
unlock
, the lowest is
NZ$519m 10.74%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 NZ$469m 24.20%
2027
NZ$563m 20.12%
unlock
2028
NZ$649m 15.38%
unlock
2029
NZ$760m 16.98%
unlock
2030
NZ$868m 14.26%
unlock

Net Margin

2026 20.30% 8.74%
2027
21.74% 7.12%
unlock
2028
22.44% 3.22%
unlock
2029
23.50% 4.72%
unlock
2030
23.78% 1.19%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Mar '26 2027
Estimates
Earnings Per Share NZ$ 0.79 0.96
23.44% 21.52%
P/E 46.93
EV/Sales 10.13

15 Analysts have issued a Fisher & Paykel Healthcare forecast for earnings per share. The average Fisher & Paykel Healthcare EPS is

NZ$0.96
unlock
. This is
21.52% higher
unlock
than earnings per share in the financial year 2026. The highest EPS forecast is
NZ$1.04 31.65%
unlock
, the lowest is
NZ$0.88 11.39%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 NZ$0.79 23.44%
2027
NZ$0.96 21.52%
unlock
2028
NZ$1.11 15.63%
unlock
2029
NZ$1.29 16.22%
unlock
2030
NZ$1.48 14.73%
unlock

P/E ratio

Current 56.96 4.87%
2027
46.93 17.61%
unlock
2028
40.68 13.32%
unlock
2029
34.77 14.53%
unlock
2030
30.43 12.48%
unlock

Based on analysts' sales estimates for 2027, the Fisher & Paykel Healthcare stock is valued at an EV/Sales of

10.13
unlock
and an P/S ratio of
10.25
unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 11.36
2027
10.13 10.87%
unlock
2028
9.06 10.54%
unlock
2029
8.11 10.46%
unlock
2030
7.18 11.45%
unlock

P/S ratio

Current
2027
10.25 10.84%
unlock
2028
9.17 10.54%
unlock
2029
8.21 10.46%
unlock
2030
7.27 11.45%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today